FNEVF yields 4.23% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, FNEVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FNEVF + PFE for your $10,000?
Fraser and Neave, Limited engages in the food and beverage, and publishing and printing businesses in Singapore, Malaysia, Thailand, Vietnam, and internationally. The company operates through Beverages, Dairies, Printing and Publishing, and Others segments. It produces and sells beverages, including 100PLUS isotonic drinks, F&N NUTRISOY soya milk, F&N sparkling drinks, F&N ICE MOUNTAIN drinking and sparkling water, F&N NUTRIWELL Asian drinks, F&N SEASONS Asian drinks and fruit teas, F&N FRUIT TREE FRESH juice drinks, and F&N cordials. The company also provides dairy products comprising sweetened condensed milk, evaporated milk, pasteurized milk and tea, UHT milk, juices, yoghurt, and ice cream primarily under the F&N MAGNOLIA, F&N, FARMHOUSE, and F&N KING'S brand names. In addition, it publishes education, general interest, and business information content under the MARSHALL CAVENDISH brand; provides digital and offset print services; distributes books and magazines; and retails English language books under the TIMES BOOKSTORES brand. The company was founded in 1883 and is headquartered in Singapore. Fraser and Neave, Limited is a subsidiary of TCC Assets Limited.
Full FNEVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.